EUCTR2012-004892-37-BE进行中(未招募)1 期
Acetylcysteine in patients with Sickle Cell Disease: Reducing the incidence of daily life pain in patients with sickle cell disease - NAC Trial
Academic Medical Center0 个研究点目标入组 140 人开始时间: 2014年10月21日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Age 12 years or older
- •-Sickle cell disease, either homozygous sickle cell disease (HbSS), HbSC sickle cell
- •disease, HbSß0 or HbSß+ thalassemia.
- •Genotype needs to be confirmed by high performance liquid chromatography.
- •-History of at least 1.0 painful crisis per year in the past 3 years.
- •A crisis will be defined here as a patient defined, painful, sickle cell related episode of at least 24 hours where a subject experienced significant impediments in his/her daily activities, and pain medication had to be taken. A visit to a medical facility is not obligatory in this definition.
- •-Written informed consent from patient/parent/guardian is given.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 30
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 90
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •-Chronic blood transfusion or transfusion in the preceding 3 months
- •-Painful crisis in the last 4 weeks (with respect to the moment of inclusion).
- •A crisis will be defined as above; a patient defined, painful, sickle cell related episode of at least 24 hours where the subject experienced significant impediments in his/her daily activities, and pain medication had to be taken. A visit to a medical facility is not obligatory in this definition.
- •-Pregnancy, breast feeding or the desire to get pregnant in the following 7 months
- •-Known active gastric/duodenal ulcers
- •-Hydroxycarbamide (HC) treatment with unstable dose in the last 3 months or started on
- •HC shorter then 6 months prior to study.
- •-Known poor compliance in earlier trials regarding the completion of pain diaries.
- •-Insufficient compliance in run-in period.
- •Participants that do not show up for their follow-up visit without prior notice, that not bring
- •their diary or with less than 80% of the days in the pain diary filled in, will be excluded from participation in this trial and will not be randomized.
研究者
相似试验
进行中(未招募)
1 期
Acetylcysteine in patients with Sickle Cell Disease: Reducing the incidence of daily life pain in patients with sickle cell diseaseSickle CellMedDRA version: 15.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004850EUCTR2012-004892-37-NLAcademic Medical Center140
进行中(未招募)
不适用
Acetylcysteine in patients with Sickle Cell Disease: Reducing the incidence of daily life pain in patients with sickle cell diseaseMedDRA version: 17.1Level: LLTClassification code 10002077Term: Anaemia sickle cellSystem Organ Class: 100000004850MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851Sickle Cell DiseaseEUCTR2012-004892-37-GBAcademic Medical Center, Department of Haematology, University of Amsterdam140
招募中
不适用
Acetylcysteine in Patients With Sickle Cell Disease (NAC).Sickle Cell DiseaseSickle Cell AnemiaPainful CrisisPainSikkelcel ziekteSikkelcel anemiePijnlijke crisePijnNL-OMON28196Academic Medical Center, Amsterdam140
尚未招募
不适用
Acetylcysteine for Treatment of Sickle Cell Diseasesickle cell disease10018902NL-OMON30544Academisch Medisch Centrum10
进行中(未招募)
不适用
Acetylcysteine for Treatment of Sickle Cell Disease - N-acetylcystein for Sickle Cell DiseasePatients homozygous for sickle cell diseaseMedDRA version: 8.1Level: LLTClassification code 10040644Term: Sickle cell diseaseEUCTR2006-005889-40-NLAcademic Medical Centre10
